5-141208974-A-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_018932.4(PCDHB12):ā€‹c.67A>Gā€‹(p.Met23Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000021 in 1,427,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 0.0000021 ( 0 hom. )

Consequence

PCDHB12
NM_018932.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.653
Variant links:
Genes affected
PCDHB12 (HGNC:8683): (protocadherin beta 12) This gene is a member of the protocadherin beta gene cluster, one of three related gene clusters tandemly linked on chromosome five. The gene clusters demonstrate an unusual genomic organization similar to that of B-cell and T-cell receptor gene clusters. The beta cluster contains 16 genes and 3 pseudogenes, each encoding 6 extracellular cadherin domains and a cytoplasmic tail that deviates from others in the cadherin superfamily. The extracellular domains interact in a homophilic manner to specify differential cell-cell connections. Unlike the alpha and gamma clusters, the transcripts from these genes are made up of only one large exon, not sharing common 3' exons as expected. These neural cadherin-like cell adhesion proteins are integral plasma membrane proteins. Their specific functions are unknown but they most likely play a critical role in the establishment and function of specific cell-cell neural connections. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03200215).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PCDHB12NM_018932.4 linkuse as main transcriptc.67A>G p.Met23Val missense_variant 1/1 ENST00000239450.4 NP_061755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PCDHB12ENST00000239450.4 linkuse as main transcriptc.67A>G p.Met23Val missense_variant 1/1 NM_018932.4 ENSP00000239450 P1Q9Y5F1-1
ENST00000624192.1 linkuse as main transcriptn.72+32699T>C intron_variant, non_coding_transcript_variant 5
PCDHB12ENST00000622978.1 linkuse as main transcriptc.67A>G p.Met23Val missense_variant 1/22 ENSP00000485352
PCDHB12ENST00000624949.1 linkuse as main transcriptc.-99+32A>G intron_variant 2 ENSP00000485303 Q9Y5F1-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.00000451
AC:
1
AN:
221720
Hom.:
0
AF XY:
0.00000840
AC XY:
1
AN XY:
119078
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000967
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000210
AC:
3
AN:
1427356
Hom.:
0
Cov.:
30
AF XY:
0.00000283
AC XY:
2
AN XY:
707666
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000253
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.11e-7
Gnomad4 OTH exome
AF:
0.0000170
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.00000824
AC:
1
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 23, 2024The c.67A>G (p.M23V) alteration is located in exon 1 (coding exon 1) of the PCDHB12 gene. This alteration results from a A to G substitution at nucleotide position 67, causing the methionine (M) at amino acid position 23 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
7.8
DANN
Benign
0.66
DEOGEN2
Benign
0.00049
.;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.017
N
LIST_S2
Benign
0.064
T;T
M_CAP
Benign
0.0028
T
MetaRNN
Benign
0.032
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.69
.;N
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.28
.;N
REVEL
Benign
0.050
Sift
Benign
0.72
.;T
Sift4G
Benign
0.17
T;T
Polyphen
0.0
.;B
Vest4
0.063
MutPred
0.35
Gain of catalytic residue at M23 (P = 0.0061);Gain of catalytic residue at M23 (P = 0.0061);
MVP
0.20
MPC
0.20
ClinPred
0.055
T
GERP RS
-1.8
Varity_R
0.033
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs782082200; hg19: chr5-140588546; COSMIC: COSV53400764; COSMIC: COSV53400764; API